Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils

H Suzuki1, M Mori, A Kai

  • 1Department of Internal Medicine and Biochemistry, School of Medicine, Keio University, Tokyo, Japan.

Insights

Rebamipide treatment helped clear Helicobacter pylori infection and reduced stomach damage in gerbils. This mucosal protective agent shows promise for managing H. pylori-related gastric injury.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pharmacology

Background:

  • Helicobacter pylori infection is a major cause of gastric mucosal lesions.
  • Ethanol pretreatment exacerbates H. pylori-associated gastric injury.
  • Rebamipide is a known mucosal protective agent.

Purpose of the Study:

  • To investigate the efficacy of rebamipide in mitigating H. pylori-induced gastric injury.
  • To evaluate rebamipide's effect on H. pylori colonization in a gerbil model.

Main Methods:

  • Male Mongolian gerbils were orally inoculated with H. pylori.
  • Ethanol was administered to induce gastric injury prior to H. pylori inoculation.
  • Gerbils received either a standard diet or a diet containing rebamipide.
  • H. pylori infection and gastric damage were assessed via bacterial culture and histology.

Main Results:

  • H. pylori persisted with significant leukocyte infiltration in ethanol-treated gerbils.
  • In the rebamipide-treated group, H. pylori was naturally cleared in 67% of gerbils.
  • Rebamipide administration significantly mitigated mucosal damage compared to controls.

Conclusions:

  • Rebamipide demonstrates potential in reducing H. pylori colonization levels.
  • Rebamipide may inhibit the formation of gastric lesions associated with H. pylori infection.